SCHEMBL18859542

SCHEMBL18859542

c1ccc2cc(-c3ccc(-c4nc5c6ccccc6sc5c5ccccc45)cc3)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNKS O95271 2/20 0.40
▸ TNKS2 Q9H2K2 2/20 0.40
▸ ESR1 P03372 1/20 0.39
▸ ESR2 Q92731 1/20 0.39
▸ LIMK1 P53667 3/20 0.36
▸ HTR2B P41595 1/20 0.36
▸ HTR5A P47898 1/20 0.36
▸ CDK5 Q00535 1/20 0.36
▸ CDK5R1 Q15078 1/20 0.36
▸ ALOX5 P09917 2/20 0.36
▸ CYP17A1 P05093 1/20 0.36
▸ CYP19A1 P11511 1/20 0.36
▸ CYP11B1 P15538 1/20 0.36
▸ CYP11B2 P19099 1/20 0.36
▸ MAPK8 P45983 1/20 0.35
▸ MAPK9 P45984 1/20 0.35
▸ MAPK10 P53779 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ PIM1 P11309 2/20 0.35
▸ PIM2 Q9P1W9 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18859549 0.91 TNKS (0.38) TNKSTNKS2ESR1ESR2LIMK1
SCHEMBL18859547 0.88 TNKS (0.38) TNKSTNKS2LIMK1CDK5CDK5R1
SCHEMBL18859556 0.87 TNKS (0.40) TNKSTNKS2LIMK1CDK5CDK5R1
SCHEMBL24280201 0.85 LIMK1 (0.39) TNKSTNKS2ESR1ESR2LIMK1
SCHEMBL18859782 0.84 TNKS (0.43) TNKSTNKS2LIMK1CDK5CDK5R1
SCHEMBL22273892 0.84 ALOX5 (0.42) TNKSTNKS2ALOX5MAPTPIM1
SCHEMBL17297437 0.83 TNKS (0.38) TNKSTNKS2ESR1ESR2LIMK1
SCHEMBL24280155 0.83 ALOX5 (0.41) TNKSTNKS2ALOX5MAPTPIM1
SCHEMBL18859772 0.81 TNKS (0.42) TNKSTNKS2LIMK1CDK5CDK5R1
SCHEMBL22274519 0.81 TUBB4A (0.32) TNKSTNKS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10644244-B2 Heterocyclic compound and organic light emitting device using same LT MATERIALS CO., LTD. (KR) 2020-05-05 — — US disclosed
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-18 — — US disclosed
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME CRY1, CRY2, CYBA TNKS 1638/4885TNKS2 1814/4885ESR1 155/4885
US-10644244-B2 Heterocyclic compound and organic light emitting device using same CRY1, CRY2, CYBA TNKS 1638/4885TNKS2 1814/4885ESR1 155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback